StaticPageTitle

EVALDO STANISLAU AFFONSO DE ARAUJO

Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/47 - Laboratório de Hepatologia por Vírus, Hospital das Clínicas, Faculdade de Medicina
Lattes
Formas de citação no OPI
AFFONSO-DE-ARAUJO, Evaldo S.
ARAUJO, E. S. Affonso de
ARAUJO, Evaldo S.
ARAUJO, E. Stanislau Affonso de
ARAúJO, Evaldo Stanislau Affonso
ARAUJO, Evaldo Stanislau A.
ARAUJO, Evaldo Stanislau
ARAÚJO, Evaldo Stanislau Affonso de
ARAUJO, Evaldo Stanislau Affonso de
ARAUJO, Evaldo S. A. de
ARAUJO, Evaldo Stanislau Affonso
ARAUJO, Evaldo S. A.
ARAúJO, Evaldo Stanislau Affonso de
ARAUJO, E. S. A.

Produções no OPI
Exportar toda produção em .RIS
# Data de publicação Tipo Título Citações WoS Citações Scopus
1 2018 article Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis 1 1
2 2016 article HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir 40 46
3 2016 bookPart Dengue e Febre Amarela
4 2015 article CD8+T Lymphocyte Expansion, Proliferation and Activation in Dengue Fever 16 18
5 2014 conferenceObject SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION IN TREATMENT-NAIVE EUROPEAN PATIENTS IN THE QUEST-1 AND QUEST-2 PHASE III TRIALS 3
6 2014 article Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial 270 294
7 2014 article Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection 27 32
8 2013 article Inter- and Intra-Host Viral Diversity in a Large Seasonal DENV2 Outbreak 27 30
9 2013 conferenceObject SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAIVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL 48
10 2013 conferenceObject Simeprevir (TMC435) with peginterferon/ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naive patients: efficacy in difficult-to-treat patient sub-populations in the QUEST 1 and 2 phase III trials 9
11 2013 bookPart Hepatites Virais: Noções Gerais e no Contexto da Prática Cirúrgica
12 2013 bookPart Dengue
13 2012 conferenceObject Lack of association between SOCS3 rs4969170 and interleukin 28B genes with therapeutic response in Brazilian HCV carriers treated with PEG-IFN/RBV 0
14 2012 article Low Sensitivity of NS1 Protein Tests Evidenced during a Dengue Type 2 Virus Outbreak in Santos, Brazil, in 2010 25 27
15 2012 article A Summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses 1 2
16 2011 article Hepatitis C therapy in 2011: is less more, is more less? 0 1
17 2011 article Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients 5 7
18 2011 article Pharmacodynamics of PEG-IFN-alpha-2a and HCV Response as a Function of IL28B Polymorphism in HIV/HCV-Coinfected Patients 19 21


Coautorias FMUSP-HC
# Nome de citação do coautor Atuação nProd
1 KALLAS, Esper George FM MCM 4
2 LEVI, Jose Eduardo HC LIM/52 4
3 VILLAS-BOAS, Lucy Santos HC LIM/52 4
4 PANNUTI, Claudio Sergio FM MIP 4
5 MELO, Carlos E. HC LIM/47 3
6 BARONE, Antonio A. FM MIP 3
7 ROMANO, Camila M. HC LIM/52 3
8 CENTRONE, Cristiane C. IMT 2
9 CARVALHO, Karina Inacio FM 2
10 LUNA, Expedito Jose Albuquerque IMT IMT 2
11 FELIX, Alvina Clara FM 1
12 RODRIGUES, Celia Lima FM 1
13 MATOS, Andreia Manso de FM 1
14 CAVALHEIRO, N. de Paula HC LIM/47 1
15 MELO, E. S. de HC ICESP 1
16 MENDES-CORREA, Maria C. FM MIP 1
17 MANCHIERO, Caroline HC LIM/47 1
18 PESSOA, Mario G. HC ICHC 1
19 ROSA, Daniela Santoro FM 1
20 BOULOS, Marcos FM MIP 1
21 SILVA, Wanessa Cardoso da FM 1
22 MARTINS, Luciane P. FM 1
23 TENGAN, Fatima M. FM MIP 1